antibodi
fragment
sequenc
avail
suitabl
straightforward
engin
express
eukaryot
prokaryot
system
produc
fusion
conveni
tag
becom
reagent
pair
select
bind
capac
orthogon
function
sever
kind
immunoreag
compos
nanobodi
either
larg
protein
short
sequenc
design
provid
inexpens
readytous
biolog
tool
possibl
choos
among
altern
express
strategi
critic
fusion
moieti
might
requir
specif
condit
correct
fold
posttransl
modif
case
nanobodi
product
trend
toward
simpler
reliabl
bacteri
method
substitut
cumbersom
process
requir
use
eukaryot
system
use
disappear
restrict
case
final
immunoconstruct
must
featur
obtain
prokaryot
cell
time
bacteri
express
evolv
convent
procedur
consid
exclus
nanobodi
nanobodyfus
accumul
periplasm
sever
report
show
advantag
cytoplasm
express
surfacedisplay
secret
least
applic
final
increas
interest
use
model
short
nanobodi
sequenc
develop
silico
methodolog
aim
optim
yield
stabil
affin
recombin
antibodi
nanobodi
vhh
correspond
heavychain
variabl
domain
express
camelida
devoid
domain
well
light
chain
fig
repres
smallest
antibodi
fragment
kda
abl
preserv
bind
affin
specif
origin
whole
antibodi
appreci
structur
stabil
simpl
engin
reagent
suitabl
vitro
vivo
applic
respect
convent
igg
kda
tini
dimens
nanobodi
confer
exclus
capac
bind
cryptic
epitop
virus
characterist
present
could
particularli
use
produc
reagent
suitabl
coronaviru
studi
year
emerg
vhh
effect
crystallographi
chaperon
molecular
tool
protein
structur
character
conveni
carrier
radioisotop
extrem
short
halflif
use
vivo
pet
spect
imag
valid
immunoreag
control
orient
function
nanoparticl
nanogel
biosensor
even
intern
mammalian
cell
provid
suitabl
leader
peptid
recent
minim
dimens
particularli
appreci
scientist
look
binder
suitabl
optim
perform
super
resolut
microscopi
creat
tandem
chimer
antigen
receptor
car
show
higher
target
specif
due
possibl
bind
simultan
multipl
antigen
final
short
sequenc
make
simplest
antibodyderiv
candid
ration
mutagenesi
silico
improv
biophys
featur
parallel
interest
technic
advantag
attent
nanobodi
grown
exponenti
expir
patent
restrict
use
consequ
late
mani
new
group
explor
field
contribut
develop
nanobodyrel
public
year
year
ago
becam
tensyear
aros
sever
hundr
evidenc
pubm
statist
meant
wider
spectrum
vhh
applic
propos
methodolog
altern
step
process
start
nanobodi
isol
proce
product
engin
develop
matur
immunoreag
featur
use
final
applic
instanc
case
nanobodi
chosen
accord
resist
physic
chemic
condit
specif
determin
antigen
epitop
select
clonabl
molecul
directli
produc
fusion
immunoreag
select
function
characterist
differ
format
domain
combin
instanc
chromobodi
nuclear
local
signal
use
actin
identif
correl
light
electron
microscopi
fusion
immunoreag
either
readytous
suitabl
control
custom
function
modular
chemic
partner
fig
instanc
tag
snap
allow
nanobodi
derivat
molecul
present
benzylguanin
group
advantag
shortcom
nanobodybas
reagent
differ
structur
configur
bind
select
valenc
larg
investig
term
potenc
efficaci
toxic
paradigmat
exampl
offer
antivir
therapeut
trimer
nanobodi
reduc
mass
singl
domain
recombin
natur
enabl
straightforward
product
trival
reagent
significantli
smaller
mass
strike
higher
neutral
capac
monoval
molecul
commerci
human
monoclon
antibodi
palivizumab
present
larg
array
vector
avail
produc
custom
vhh
prokaryot
eukaryot
system
accord
function
characterist
must
serv
final
applic
final
recombin
nanobodi
direct
toward
differ
igg
epitop
made
avail
recent
provid
valid
clonal
simpletofunction
altern
commerci
polyclon
secondari
antibodi
sinc
vhh
usual
express
function
high
yield
bacteria
express
expens
demand
system
mammalian
cell
must
justifi
instanc
case
nanobodi
produc
fcfusion
restor
adcc
cdc
effector
function
vivo
increas
appar
bind
affin
avid
effect
provid
result
bival
molecul
nanobodi
fuse
human
fc
express
purifi
cell
suspens
specif
induc
adccand
cdcmediat
cell
death
leukemia
cell
overexpress
receptor
affect
neg
cell
cell
use
produc
reconstitut
nanobodyfc
construct
necessari
fabric
immunotoxin
mean
inteinmedi
splice
assembl
gelonin
fusion
nanobodi
human
fc
domain
produc
also
cho
cell
immunoreag
suitabl
botulinum
neurotoxin
protect
vivo
construct
design
extend
circul
time
immunoreag
inde
treat
mice
remain
protect
even
day
vhhfc
administr
howev
fusion
nanobodi
fc
perform
provid
tag
suitabl
vitro
applic
bind
protein
secondari
antibodi
possibl
produc
notglycosyl
vhhfc
total
preserv
bind
capac
bacteria
protein
often
use
combin
antibodi
commonli
difficult
produc
bacteria
horseradish
peroxidas
nanobodyperoxidas
fusion
would
directli
suitabl
colorimetr
electrochem
diagnost
express
mammalian
cell
construct
allow
obtain
chimera
moieti
function
success
use
competit
elisa
recent
search
product
equival
immunoreag
bacteria
move
two
promis
altern
first
case
evolv
version
soybean
ascorb
peroxidas
fuse
nanobodi
construct
fold
success
bifunct
reagent
secret
bacteri
periplasm
second
nanobodi
preserv
antigen
select
produc
bacteri
cytoplasm
fuse
tag
tag
use
bind
coval
gquadruplex
dnazym
peroxidas
activ
nanobodi
might
requir
express
mammalian
cell
also
must
act
intrabodi
name
binder
preserv
function
even
produc
reduc
environ
cytoplasm
case
intrabodi
express
vivo
tempor
control
induc
binder
accumul
specif
moment
applic
multipl
instanc
fluoresc
nanobodi
express
determin
physiolog
phase
host
cell
follow
fate
correspond
antigen
without
interf
activ
way
specif
label
distinct
antigen
subcellular
region
clear
advantag
nanobodi
convent
antibodi
structur
simplic
singl
disulfid
bond
sever
case
obligatori
reach
stabl
heavyand
lightchain
variabl
domain
contribut
antigenselect
bind
surfac
convent
igg
wherea
heavychain
variabl
domain
camelida
igg
provid
alon
complet
epitop
antigen
specif
recognit
therefor
minim
antibodi
fragment
still
abl
recogn
antigen
scfv
vhh
respect
exactli
contact
surfac
vhh
paratop
mostli
form
amino
acid
belong
three
cdr
wherea
framework
residu
constitut
conserv
structur
domain
organ
nanobodi
singledomain
recombin
protein
fuse
minim
cystein
larger
tag
snap
control
function
well
protein
function
fluoresc
protein
enzym
fusion
immunoreag
coupl
target
sequenc
select
deliveri
desir
subcellular
compart
furthermor
nanobodi
arrang
bior
multival
homoor
heteromolecul
vhh
protein
improv
characterist
celltyp
specif
avid
circul
time
combin
targetselect
nanobodi
effector
activ
partner
function
fold
consequ
larg
share
correct
fold
cytoplasm
bound
pass
cellular
secret
pathway
achiev
nativ
conform
condit
exploit
design
intrabodi
compet
bind
specif
epitop
antigen
molecul
present
cell
immunoprecipit
target
impair
patholog
process
aggreg
possibl
use
intrabodi
select
modifi
activ
target
protein
studi
function
vivo
eukaryot
cell
achiev
tag
target
protein
use
combin
nanobodi
recogn
tag
antitag
nanobodi
intrabodi
featur
success
exploit
induc
visual
degrad
reloc
trap
modif
protein
interest
degradfp
system
exploit
antigfpfbox
fusion
nanobodi
promot
ubiquitin
bound
antigen
consequ
degrad
mediat
proteasom
machineri
initi
optim
fli
concept
recent
adapt
extend
model
organ
c
elegan
zebrafish
perform
ultrastructur
local
protein
interact
expect
futur
proteinspecif
nanobodi
substitut
antitag
binder
way
flexibl
multidimension
analys
possibl
howev
despit
fact
increas
number
nanobodi
specif
human
protein
commun
wait
similar
reagent
suitabl
relev
protein
c
elegan
zebrafish
cytoplasm
nanobodi
express
mammalian
cell
also
exploit
understand
epitop
specif
antibodi
must
neutral
viru
physiolog
environ
specif
nanobodi
rev
protein
hiv
stabli
express
mammalian
cell
line
capac
block
viru
replic
evalu
presenc
differ
natur
rev
variant
therefor
possibl
map
critic
residu
involv
nanobodyantigen
contact
predict
potenti
efficaci
nanobodi
major
subtyp
recombin
express
eukaryot
protein
mammalian
cell
also
meaning
necessari
obtain
optim
fold
molecul
underw
physiolog
relev
posttransl
modif
monitor
express
simplifi
purif
protein
fuse
dualfunct
tag
yfp
immunopurifi
mean
antiyfp
nanobodi
immunopurif
recombin
antigen
success
perform
also
coexpress
specif
nanobodi
cell
bacteri
cytoplasm
periplasm
follow
purif
complex
report
demonstr
possibl
appli
strategi
mammalian
cell
mammalian
antigen
purifi
immunoaffin
chromatographi
use
nanobodi
mammalian
express
also
instrument
produc
recombin
extracellular
vesicl
display
nanobodi
specif
tumor
biomark
modifi
vesicl
could
enabl
select
deliveri
therapeut
cargo
target
cell
express
nanobodyrecogn
antigen
pichia
pastori
sever
plant
propos
altern
eukaryot
biofactori
product
recombin
nanobodi
despit
feasibl
demonstr
effort
succeed
convinc
commun
advantag
use
organ
instead
convent
one
apart
necess
set
new
ad
hoc
infrastructur
new
approach
requir
protocol
optim
troubleshoot
capac
underlin
report
indic
p
pastori
strain
prone
misincorpor
amino
acid
specif
ferment
condit
pichia
success
use
produc
nanobodi
correspond
human
fcfusion
target
middl
east
respiratori
syndrom
coronaviru
merscov
receptorbind
domain
construct
character
strong
neutral
activ
unluckili
author
claim
concern
econom
reason
choos
express
system
support
experiment
data
comparison
altern
method
relev
exampl
offer
recombin
product
structur
complex
hybrid
antibodi
compos
camelid
vhh
igafc
domain
author
look
altern
bacteria
pichia
prefer
plantbas
express
reliabl
yield
reagent
good
protect
effect
gastrointestin
infect
piglet
innov
strategi
exploit
nanobodi
modifi
vivo
condit
plant
alreadi
mention
therapeut
efficaci
would
difficult
obtain
use
convent
antibodi
larger
prone
fold
incorrectli
nanobodi
direct
grapevin
fanleaf
viru
stabli
express
n
benthamiana
grapevin
rootstock
abl
neutral
target
confer
resist
virusinduc
degen
diseas
convent
method
produc
recombin
nanobodi
promot
secret
e
coli
periplasm
oxid
condit
subcellular
compart
favor
format
disulfid
bond
stabil
nanobodi
structur
fold
binder
usual
recov
supernat
step
osmot
shock
perform
permeabil
bacteri
outer
membran
heat
incub
supernat
success
appli
purifi
rel
thermalresist
vhh
precipit
temperaturesensit
e
coli
protein
otherwis
affin
purif
repres
standard
classic
metal
affin
chromatographi
pair
maltos
bind
affin
purif
improv
puriti
recov
nanobodi
streptavidinmutein
affin
chromatographi
appli
recov
antiegfr
vhhavi
tag
fusion
biotinyl
vivo
approach
enabl
also
obtain
mono
tetraval
nanobodi
coupl
monobiotinyl
vhh
wild
type
streptavidin
comparison
function
effect
binder
demonstr
tetraval
form
effect
control
tumor
cell
prolifer
periplasm
produc
biotinyl
nanobodi
exploit
function
microbubbl
use
ultrasound
contrast
agent
diagnost
swine
influenza
identif
ochratoxin
contamin
cereal
periplasm
express
also
success
exploit
produc
nanobodi
suitabl
react
maleimid
fluorophor
fusion
vhh
nanoluciferas
use
bioluminesc
immunoreag
recov
correctfold
nanobodyintein
fusion
protein
suitabl
thioester
reaction
final
fabric
immunomicel
express
rout
also
prefer
produc
hybrid
molecul
antilysozym
nanobodi
insert
solventexpos
loop
moieti
conserv
function
purif
periplasm
accumul
recombin
protein
two
major
drawback
lead
protein
aggreg
low
yield
first
due
presenc
incomplet
chaperon
machineri
impair
correct
fold
high
express
rate
second
consequ
limit
volum
compart
lead
overcrowd
altern
product
nanobodi
nanobodyfus
construct
success
demonstr
bacteri
cytoplasm
use
secret
rout
see
section
nanobodi
fold
nativ
function
structur
secret
surfac
bacteri
yeast
cell
nanobodi
display
use
screen
purpos
prepar
wholecel
biosensor
advantag
repres
display
function
macromolecul
cell
surfac
multipl
larg
exploit
sever
class
protein
particular
enzym
necess
purifi
recombin
binder
engin
requir
link
surfac
alreadi
orient
outward
bacteria
directli
spot
surfac
use
immunocaptur
element
biosensor
captur
detect
regent
elisa
test
altern
capac
agglutin
solut
exploit
quantifi
antigen
present
liquid
sampl
system
therefor
faster
less
expens
simpler
implement
convent
protocol
forese
protein
purif
function
immobil
despit
imposs
quantifi
exactli
nanobodi
concentr
e
coli
sampl
binder
amount
tune
control
level
vhh
express
nanobodi
display
bacteria
coexpress
cytoplasm
fluoresc
protein
obtain
color
live
immunoreag
suitabl
light
microscopi
flow
cytometri
applic
nanobodi
also
display
bacteria
aim
facilit
cell
target
vivo
specif
nanobodi
expos
salmonella
cell
increas
select
accumul
posit
tumor
consequ
decreas
growth
solid
tumor
proofofprincipl
experi
nanobodi
anchor
e
coli
mean
spytagspycatch
ligat
system
case
bacteria
display
spytag
avail
bind
spycatcherfus
antigfp
antibodi
cours
method
expand
select
nanobodi
specif
antigen
could
instanc
use
decor
viru
likeparticl
nanobodi
suitabl
improv
target
deliveri
nanobodi
display
exploit
also
prepar
escherichia
coli
modifi
tunabl
modular
platform
studi
cellcel
adhes
multicellular
selfassembl
approach
enabl
induc
select
adhes
orthogon
antigen
librari
design
welldefin
morpholog
use
studi
organ
multicellular
structur
yeast
surfac
display
larg
use
also
pan
antibodi
fragment
librari
enabl
sort
select
clone
flowcytometri
repres
huge
advantag
phage
display
requir
manual
screen
clone
recov
pan
interest
recent
propos
coupl
nanobodi
select
possibl
releas
directli
yeast
cell
reduct
induc
dtt
addit
disulfid
bond
link
display
protein
vhh
sinc
system
nanobodi
express
fuse
tag
compat
multipl
altern
label
first
biotinyl
directli
adsorb
streptavidin
instanc
spr
analysi
without
necess
subclon
express
purifi
also
mammalian
cell
display
nanobodi
found
interest
applic
use
modif
cell
chimer
antigen
receptor
car
suitabl
cancer
immunotherapi
vhh
prefer
scfv
consid
less
immunogen
stabl
compact
nanocar
bacteri
cytoplasm
reduc
environ
impair
format
nanobodi
intern
disulfid
bond
howev
sever
vhh
fold
function
structur
independ
presenc
disulfid
bond
disulfid
bondindepend
nanobodi
intrabodi
success
produc
e
coli
cytoplasm
even
fuse
larg
partner
cucurmosin
toxin
sinc
preliminari
result
indic
antibacilu
anthraci
nanobodi
stabl
function
intrabodi
anderson
et
al
express
fuse
beta
galactosidas
directli
cytoplasm
tuner
e
coli
shibuya
et
al
manag
coexpress
bacteri
cytoplasm
nanobodi
fuse
complementari
split
intein
moieti
obtain
bispecif
vhh
construct
incel
transsplic
wherea
nanobodi
engin
extra
cystein
ascorb
peroxidas
function
recov
product
neb
express
f
cell
anoth
nanobodi
intrabodi
featur
gener
bind
alfatag
effect
use
detect
vivo
interact
pulldown
experi
intrabodi
also
systemat
search
develop
therapeut
reagent
capac
recogn
block
process
protein
aggreg
involv
progress
neurodegen
disord
vhh
characterist
specif
prion
protein
identifi
select
identif
intrabodi
abil
e
coli
twinarginin
transloc
tat
system
also
exploit
noncoval
secret
protein
complex
periplasm
flitrap
function
ligandbind
identif
tatbas
recognit
associ
protein
result
nanobodi
could
express
function
binder
cell
cytoplasm
howev
reduc
cytoplasm
condit
remain
limit
factor
fold
major
vhh
approach
overcom
shortcom
express
nanobodi
cytoplasm
mutant
e
coli
strain
provid
oxid
environ
strategi
becam
avail
year
ago
appli
differ
recombin
protein
requir
disulfid
bond
fold
nativ
structur
progress
improv
introduct
effici
strain
rosettagami
b
shuffl
cell
use
cytoplasm
product
nake
nanobodi
fusion
variant
contain
cterminu
inteinchitin
domain
suitabl
sitespecif
alkyn
function
requir
reduc
condit
function
one
case
confirm
bind
properti
nonmodifi
nanobodi
produc
periplasm
preserv
binder
express
fusion
reagent
cytoplasm
shuffl
cell
differ
approach
reli
use
wild
type
bacteria
reduc
cytoplasm
parallel
overexpress
togeth
nanobodi
interest
sulfhydryl
oxidas
dsbc
isomeras
procedur
enabl
produc
unmodifi
nanobodi
also
demand
molecul
nanobodi
fusion
gfp
fcdomain
decreas
bind
capac
secret
recombin
protein
method
enabl
recov
target
cultur
media
amount
contamin
significantli
reduc
lysi
necessari
step
centrifug
filtrat
must
consid
larger
volum
requir
longer
load
time
chromatographi
hemolysin
secret
pathway
success
exploit
secret
function
nanobodi
directli
cultur
media
howev
low
obtain
yield
question
overal
advantag
methodolog
anoth
secret
strategi
enabl
recoveri
biotinyl
nanobodi
fuse
avitag
also
case
potenti
advantag
procedur
discuss
contrast
secret
clearli
meaning
use
effect
pathway
deliv
vivo
neutral
nanobodi
produc
lactobacillu
reach
target
rotaviru
digest
tract
piglet
inclus
bodi
recogn
long
time
conveni
sourc
rel
homogen
recombin
protein
structur
characterist
nanobodi
would
indic
refold
protocol
rel
simpl
optim
nevertheless
approach
extens
use
nanobodi
probabl
relev
part
fold
correctli
intrabodi
other
conveni
obtain
mean
procedur
describ
previou
section
elev
refold
yield
report
nanobodi
express
inclus
bodi
bacteri
cytoplasm
metal
affin
purifi
solubil
urea
structur
function
integr
assess
accur
work
compar
periplasm
yield
solubl
nanobodi
amount
recov
refold
binder
inclus
bodi
accumul
cytoplasm
term
function
binder
best
refold
protocol
periplasm
express
provid
similar
yield
author
test
higher
number
refold
combin
succeed
increas
significantli
yield
solubl
function
nanobodi
recov
inclus
bodi
bind
characterist
refold
nanobodi
confirm
comparison
measur
use
nanobodi
recov
solubl
fraction
short
sequenc
nanobodi
residu
critic
reduc
calcul
time
necessari
ration
silico
optim
biophys
characterist
compar
effort
would
necessari
model
larger
immunomolecul
furthermor
nanobodi
suitabl
xray
crystallographi
nmr
analys
therefor
sever
structur
avail
simul
conform
new
candid
recent
structur
inform
also
use
understand
specif
bind
pattern
exist
antigen
vhh
fortun
combin
structur
data
avail
short
sequenc
stimul
search
model
approach
abl
suggest
mutant
perform
better
nanobodi
initi
isol
biopan
unluckili
direct
comparison
result
obtain
convent
wetlab
approach
base
random
mutagenesi
initi
candid
follow
stringent
vitro
select
step
silico
model
yet
report
would
interest
evalu
necessari
effort
resourc
achiev
specif
two
altern
consid
alreadi
accomplish
convent
antibodi
avail
data
suggest
smart
convent
approach
still
assur
result
silico
system
provid
far
algorithm
becom
progress
competit
follow
exampl
show
encourag
result
silico
protocol
follow
differ
strategi
anticip
potenti
effect
specif
multipl
singl
mutat
instanc
success
comput
affin
matur
strategi
base
combin
ration
mutat
hotspot
design
protocol
assist
design
antibodi
protein
therapeut
appli
homolog
model
target
vhh
molecular
dynam
simul
provid
singl
mutat
candid
success
combin
four
singl
mutat
result
mutant
affin
improv
two
signific
particular
result
first
affin
improv
reach
low
nanomolar
rang
k
chang
nm
second
posit
effect
associ
increas
thermal
stabil
mutant
respect
origin
nanobodi
wherea
two
paramet
invers
correl
report
deal
similar
project
anoth
case
silico
nanobodi
affin
matur
mahajan
al
identifi
key
singl
mutat
use
combin
replica
exchang
molecular
dynam
remd
umbrella
sampl
weight
histogram
method
togeth
numer
techniqu
mutat
enabl
improv
affin
nanobodi
antigen
order
magnitud
despit
absenc
highresolut
structur
nanobodi
antigen
complex
simul
could
also
exploit
explain
reason
specif
mutat
result
unstabl
nanobodi
particular
indic
colloid
aggreg
develop
even
origin
singl
molecul
fold
stabl
conform
surfac
promot
promiscu
interact
lab
probabl
elabor
nanobodi
product
strategi
optim
necess
lab
constantli
modifi
protocol
tri
updat
accord
new
observ
ever
chang
technic
option
reason
choic
briefli
describ
serv
start
point
set
custom
methodolog
sequenc
nanobodi
avail
pan
express
plan
consid
final
applic
result
construct
develop
valid
larg
array
modular
vector
base
pet
vector
scaffold
share
conserv
clone
site
nanobodi
sequenc
ncoinoti
ii
clone
cassett
insert
function
tag
fluoresc
protein
avitag
snap
free
cystein
spytag
iii
polyhi
tag
affin
purif
concept
enabl
exchang
modul
adapt
exist
construct
design
new
vector
version
larg
tag
snap
alkalin
phosphatas
slightli
affect
bind
capac
fuse
nanobodi
wherea
small
tag
free
cystein
ctag
usual
subclon
phagemid
use
synthet
gene
suitabl
last
option
compulsori
nanobodi
sequenc
identifi
search
databas
use
also
sever
sequenc
issu
pan
would
requir
mutagenesi
possess
instanc
amber
codon
alreadi
describ
elsewher
howev
notic
sometim
yield
construct
natur
sourc
ie
phage
librari
synthet
significantli
differ
particular
synthet
gene
perform
wors
origin
sequenc
unluckili
observ
base
case
knowledg
public
subject
comment
codon
optim
synthesi
servic
implement
adapt
construct
e
coli
express
experi
express
system
synthesi
process
could
detriment
express
step
mayb
increas
translat
step
level
overwhelm
fold
capac
cell
choic
express
nanobodi
fusion
larg
discuss
review
opt
bacteri
cytoplasm
accumul
presenc
sulfhydryl
oxidas
dsbc
coexpress
demonstr
suitabl
also
larg
construct
multipl
disulfid
bond
fcvhh
protein
fold
correctli
periplasm
sever
fluoresc
protein
howev
lab
set
would
allow
option
would
suggest
parallel
smallscal
express
differ
vector
also
periplasm
compar
yield
function
express
nanobodi
frequent
nanobodi
fuse
tag
offer
orthogon
function
becom
constantli
diversifi
necessari
obtain
reagent
possess
highli
differenti
featur
necessari
fulfil
alway
new
final
applic
requir
consequ
product
reli
altern
express
condit
furthermor
increas
awar
nanobodi
differenti
structur
initi
thought
specif
possess
singl
highli
uniform
paratop
shape
rather
may
build
combin
larg
spectrum
differ
conform
involv
also
framework
residu
confer
sever
altern
surfac
interact
antigen
despit
lack
experiment
report
anticip
fold
requir
differ
vhh
subtyp
might
variabl
well
consequ
refer
structur
use
model
must
select
accuraci
altogeth
probabl
larger
rather
smaller
number
express
system
necessari
achiev
product
differenti
nanobodybas
immunoreag
necessari
fulfil
futur
requir
term
function
reliabl
